August 2025
-
NICE recommends mirikizumab as a treatment option for Crohn’s disease.
Mirikizumab (Omvoh; Eli Lilly), which is already licensed to treat ulcerative colitis but at a lower dose,…
Mirikizumab (Omvoh; Eli Lilly), which is already licensed to treat ulcerative colitis but at a lower dose,…